Arcutis Biotherapeutics
Who is Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of patients living with immune-mediated dermatological diseases and conditions. With a commitment to solving the most persistent patient challenges in dermatology, Arcutis harnesses our unique dermatology development platform coupled with our dermatology expertise to build differentiated therapies against biologically validated targets. Arcutis' dermatology development platform includes a robust pipeline with multiple clinical programs for a range of inflammatory dermatological conditions, with one NDA under review with the FDA and three Phase 3 clinical data readouts anticipated by the end of 2022. The company's lead program, topical roflumilast, has the potential to advance the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis.Read More
Headquarters:
3027 Townsgate Rd, Ste 300, Westlake Village, California, 91361, United States
Phone Number:
(805) 418-5006
Employees:
147
Revenue:
$31 Million
Stock Symbol:
ARQT
Arcutis Biotherapeutics's Social Media
Popular Searches:
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics , Inc.
Arcutis Biotherapeutics
Arcutis , Inc.
Arcutis Biotherapeutics Inc
Top Competitors of Arcutis Biotherapeutics
Arcutis Biotherapeutics's Org Chart
Phone
Email
Arcutis Biotherapeutics Company Metrics
Funding
| Funding Date | Round | Amount | Investors | |
|---|---|---|---|---|
Dec 23, 2021 | Debt | $225M | SLR Capital Partners, LLC | |
Oct 21, 2019 | Series C | $94M | HBM Healthcare Investments | |
Sep 01, 2018 | Series B | $58M | OrbiMed |
See More
$391M
Total Funding Amount
$225M
Most Recent Funding Amount
4
Number of Funding Rounds
Revenue
| Quarter | Revenue |
|---|---|
'21 - Q1 | 18229000 |
'21 - Q2 | 18229000 |
Arcutis Biotherapeutics's Tech Stack
Arcutis Biotherapeutics News & Media
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 135,900 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 324,200 shares of Arcutis’ common stock to 49 newly hired employees. These awards were approved by the Compensation Committee of Arcutis’ Boa
May 5, 2022Arcutis Completes Enrollment in ARRECTOR Pivotal Phase 3 Trial of Topical Roflumilast Foam in Scalp and Body Psoriasis
WESTLAKE VILLAGE, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the enrollment of the last subject in its ARRECTOR pivotal Phase 3 trial of topical roflumilast foam in adolescents and adults with scalp and body psoriasis. Roflumilast foam is a once-daily, topical formulation of a highly potent and selective phosphodiesterase-4 (PDE4Apr 6, 2022Arcutis Highlights Growth Opportunities at Investor Day in Advance of 2022 Catalysts
WESTLAKE VILLAGE, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, outlines the company’s growth strategy and continued clinical progress of its broad immuno-dermatology pipeline during today’s Investor Day in Boston, MA at 10:30 a.m. EST.Mar 28, 2022Subscribe to "Arcutis Biotherapeutics" News
Frequently Asked Questions regarding Arcutis Biotherapeutics
Where are Arcutis Biotherapeutics’s headquarters?
Arcutis Biotherapeutics’s headquarters are in 3027 Townsgate Rd, Ste 300, Westlake Village, California, 91361, United States
What is Arcutis Biotherapeutics’s phone number?
Arcutis Biotherapeutics’s phone number is (805) 418-5006
What is Arcutis Biotherapeutics’s stock symbol?
Arcutis Biotherapeutics’s stock symbol is ARQT
What is Arcutis Biotherapeutics’s official website?
Arcutis Biotherapeutics’s official website is www.arcutis.com
What is Arcutis Biotherapeutics’s Revenue?
Arcutis Biotherapeutics’s revenue is $31 Million
What is Arcutis Biotherapeutics’s SIC code?
Arcutis Biotherapeutics’s SIC: 28,283
What is Arcutis Biotherapeutics’s NAICS code?
Arcutis Biotherapeutics’s NAICS: 541,32541
How many employees are working in Arcutis Biotherapeutics?
Arcutis Biotherapeutics has 147 employees
What is Arcutis Biotherapeutics’s industry?
Arcutis Biotherapeutics is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare
Who are Arcutis Biotherapeutics’s main competitors?
Arcutis Biotherapeutics's main competitors are: Verrica Pharmaceuticals, Atara Bio, Curemark, Aclaris Therapeutics
What is Arcutis Biotherapeutics's tech stack?
The technologies that are used by Arcutis Biotherapeutics are: Google Global Site Tag, Pantheon, Office 365, WordPress.org
Who is Arcutis Biotherapeutics's CEO?
Arcutis Biotherapeutics's CEO is Frank Watanabe
Who is Arcutis Biotherapeutics's CFO?
Arcutis Biotherapeutics's CFO is Scott Burrows
Rate Frank Watanabe as a Chief Executive Officer & President
User Ratings 
4.4/5 on G2 Crowd
Test Drive ZoomInfo's Directories
Browse Directories
